Gene therapy for chronic myelogenous leukemia (CML): A retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo
Robert C.H. Zhao, R. Scott McIvor, James D. Griffin, Catherine M. Verfaillie
Dive into the research topics of 'Gene therapy for chronic myelogenous leukemia (CML): A retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo'. Together they form a unique fingerprint.